AIM-Harvard/TrialPanorama-filtered huggingface dataset:
Study 27442601 — intervention group
Group type: EXPERIMENTAL
Intervention: Airflow limitation observed in patients with ischemic heart disease
Number of subjects: 3103
Study 27442601 — intervention group
Group type: EXPERIMENTAL
Intervention: Airflow limitation
Number of subjects: 3103
Study 27443429 — intervention group
Group type: EXPERIMENTAL
Intervention: TAVR intervention
Number of subjects: 3687
Study 27443431 — intervention group
Group type: EXPERIMENTAL
Intervention: Hybrid Coronary Revascularization (HCR)
Number of subjects: 298
Study 27443431 — intervention group
Group type: COMPARATOR
Intervention: Multivessel PCI
Number of subjects: 298
Study 27443634 — intervention group
Group type: EXPERIMENTAL
Intervention: Chemotherapy (CTh)
Number of subjects: 289
Study 27443634 — intervention group
Group type: COMPARATOR
Intervention: Healthy Controls (HCs)
Number of subjects: 289
Study 27443634 — intervention group
Group type: COMPARATOR
Intervention: Localized CRC without chemotherapy (CTh-)
Number of subjects: 289
Study 27444203 — intervention group
Group type: EXPERIMENTAL
Intervention: Heterozygous familial hypercholesterolemia (FH) patients
Number of subjects: 4132
Study 27444203 — intervention group
Group type: COMPARATOR
Intervention: Unaffected relatives
Number of subjects: 4132
Study 27445347 — intervention group
Group type: EXPERIMENTAL
Intervention: DOX-Colos (bovine colostrum)
Number of subjects: 36
Study 27445347 — intervention group
Group type: EXPERIMENTAL
Intervention: DOX-Form (formula)
Number of subjects: 36
Study 27445347 — intervention group
Group type: COMPARATOR
Intervention: SAL-Form (saline + formula)
Number of subjects: 36
Study 27445347 — intervention group
Group type: COMPARATOR
Intervention: SAL-Colos (saline + bovine colostrum)
Number of subjects: 36
Study 27445874 — intervention group
Group type: EXPERIMENTAL
Intervention: iCBIT
Number of subjects: 160
Study 27445882 — intervention group
Group type: EXPERIMENTAL
Intervention: Exercise intervention (emphasizing self-regulatory strategies for behavior change)
Number of subjects: 72
Study 27445882 — intervention group
Group type: COMPARATOR
Intervention: Stress management intervention (coping and relaxation techniques)
Number of subjects: 72
Study 27445882 — intervention group
Group type: EXPERIMENTAL
Intervention: Exercise intervention
Number of subjects: 72
Study 27445882 — intervention group
Group type: COMPARATOR
Intervention: Stress management intervention
Number of subjects: 72
Study 27446211 — intervention group
Group type: EXPERIMENTAL
Intervention: DecisionDx-UM Class 1 results
Number of subjects: 70
Study 27446211 — intervention group
Group type: COMPARATOR
Intervention: DecisionDx-UM Class 2 results
Number of subjects: 70
Study 27446211 — intervention group
Group type: COMPARATOR
Intervention: Class 2 patients monitoring and referrals
Number of subjects: 70
Study 27446991 — intervention group
Group type: EXPERIMENTAL
Intervention: xMELP assay with M-score calculation
Number of subjects: 549
Study 27446991 — intervention group
Group type: EXPERIMENTAL
Intervention: Binary M-score classifier
Number of subjects: 549
Study 27447788 — intervention group
Group type: EXPERIMENTAL
Intervention: Pressure support ventilation
Number of subjects: 17
Study 27447788 — intervention group
Group type: COMPARATOR
Intervention: Volume-controlled ventilation
Number of subjects: 17
Study 27447788 — intervention group
Group type: EXPERIMENTAL
Intervention: Both ventilation modes
Number of subjects: 17
Study 27448285 — intervention group
Group type: COMPARATOR
Intervention: Pregabalin
Number of subjects: 0
Study 27449568 — intervention group
Group type: EXPERIMENTAL
Intervention: Stillbirth or neonatal death
Number of subjects: 41348
Study 27449568 — intervention group
Group type: EXPERIMENTAL
Intervention: Early postneonatal death
Number of subjects: 41348
Study 27449568 — intervention group
Group type: EXPERIMENTAL
Intervention: Stillbirth
Number of subjects: 41348
Study 27449568 — intervention group
Group type: EXPERIMENTAL
Intervention: Higher levels of education (≥10 years)
Number of subjects: 41348
Study 27449568 — intervention group
Group type: EXPERIMENTAL
Intervention: Lower levels of education (no education)
Number of subjects: 41348
Study 27449568 — intervention group
Group type: EXPERIMENTAL
Intervention: Lower levels of education (1-9 years)
Number of subjects: 41348
Study 27449652 — intervention group
Group type: EXPERIMENTAL
Intervention: Behavioral intervention (six sessions focused on GWG)
Number of subjects: 230
Study 27449652 — intervention group
Group type: COMPARATOR
Intervention: Usual care (PRAMS respondents)
Number of subjects: 230
Study 27450106 — intervention group
Group type: EXPERIMENTAL
Intervention: Metformin
Number of subjects: 0
Study 27450106 — intervention group
Group type: COMPARATOR
Intervention: Standard-of-care therapies
Number of subjects: 0
Study 27450309 — intervention group
Group type: EXPERIMENTAL
Intervention: Proton Pump Inhibitors (PPIs)
Number of subjects: 48605
Study 27450309 — intervention group
Group type: EXPERIMENTAL
Intervention: Histamine-2 Receptor Antagonists (H2RAs)
Number of subjects: 48605
Study 27450311 — intervention group
Group type: EXPERIMENTAL
Intervention: Vagus nerve stimulation (VNS)
Number of subjects: 28
Study 27450466 — intervention group
Group type: EXPERIMENTAL
Intervention: Internet-based 8-week mindfulness program
Number of subjects: 90
Study 27450466 — intervention group
Group type: COMPARATOR
Intervention: Internet-based 4-week expressive writing program (active control)
Number of subjects: 90
Study 27450632 — intervention group
Group type: EXPERIMENTAL
Intervention: Atypical depression in probands
Number of subjects: 457
Study 27450632 — intervention group
Group type: EXPERIMENTAL
Intervention: Melancholic depression in probands
Number of subjects: 457
Study 27450632 — intervention group
Group type: EXPERIMENTAL
Intervention: Familial heritability of atypical subtype
Number of subjects: 457
Study 27450632 — intervention group
Group type: EXPERIMENTAL
Intervention: Familial heritability of melancholic subtype
Number of subjects: 457
Study 27450632 — intervention group
Group type: EXPERIMENTAL
Intervention: Melancholic depression
Number of subjects: 457
Study 27451002 — intervention group
Group type: EXPERIMENTAL
Intervention: Isocaloric fructose restriction
Number of subjects: 37
Study 27451390 — intervention group
Group type: EXPERIMENTAL
Intervention: Nivolumab (3 mg/kg intravenously every 2 weeks)
Number of subjects: 80
Study 27451390 — intervention group
Group type: EXPERIMENTAL
Intervention: Nivolumab
Number of subjects: 80
Study 27452608 — intervention group
Group type: EXPERIMENTAL
Intervention: Gene set of 13 genes
Number of subjects: 204
Study 27452608 — intervention group
Group type: COMPARATOR
Intervention: Baseline clinical variables
Number of subjects: 204
Study 27452608 — intervention group
Group type: COMPARATOR
Intervention: Clinical and pathological variables
Number of subjects: 204
Study 27452608 — intervention group
Group type: COMPARATOR
Intervention: Routine pathological variables
Number of subjects: 204
Study 27452608 — intervention group
Group type: EXPERIMENTAL
Intervention: Predictive gene set
Number of subjects: 204
Study 27453079 — intervention group
Group type: COMPARATOR
Intervention: Guanfacine (GUAN) 1-3 mg/day
Number of subjects: 207
Study 27453079 — intervention group
Group type: COMPARATOR
Intervention: D-methylphenidate extended-release (DMPH) 5-20 mg/day
Number of subjects: 207
Study 27453079 — intervention group
Group type: EXPERIMENTAL
Intervention: Combination of GUAN and DMPH (COMB)
Number of subjects: 207
Study 27453080 — intervention group
Group type: EXPERIMENTAL
Intervention: d-methylphenidate (DMPH)
Number of subjects: 182
Study 27453080 — intervention group
Group type: EXPERIMENTAL
Intervention: guanfacine (GUAN)
Number of subjects: 182
Study 27453080 — intervention group
Group type: EXPERIMENTAL
Intervention: Combination treatment with DMPH and GUAN (COMB)
Number of subjects: 182
Study 27453080 — intervention group
Group type: COMPARATOR
Intervention: Nonclinical comparison group (placebo)
Number of subjects: 182
Study 27453081 — intervention group
Group type: EXPERIMENTAL
Intervention: Guanfacine (GUAN)
Number of subjects: 179
Study 27453081 — intervention group
Group type: EXPERIMENTAL
Intervention: d-Methylphenidate (DMPH)
Number of subjects: 179
Study 27453081 — intervention group
Group type: EXPERIMENTAL
Intervention: Combination (COMB)
Number of subjects: 179
Study 27453127 — intervention group
Group type: EXPERIMENTAL
Intervention: Melody valve implant
Number of subjects: 136
Study 27453716 — intervention group
Group type: EXPERIMENTAL
Intervention: Carbohydrate-free diet for 72 hours
Number of subjects: 0
Study 27453716 — intervention group
Group type: EXPERIMENTAL
Intervention: Total starvation for 72 hours
Number of subjects: 0
Study 27453716 — intervention group
Group type: COMPARATOR
Intervention: Standard mixed meal diet (control)
Number of subjects: 0
Study 27453733 — intervention group
Group type: EXPERIMENTAL
Intervention: Insulin therapy
Number of subjects: 0
Study 27453733 — intervention group
Group type: EXPERIMENTAL
Intervention: Insulin injections
Number of subjects: 0
Study 27453733 — intervention group
Group type: EXPERIMENTAL
Intervention: Oral antidiabetic drugs (OADs)
Number of subjects: 0
Study 27453733 — intervention group
Group type: EXPERIMENTAL
Intervention: Diabetes-related distress
Number of subjects: 0
Study 27453733 — intervention group
Group type: EXPERIMENTAL
Intervention: Age
Number of subjects: 0
Study 27453733 — intervention group
Group type: EXPERIMENTAL
Intervention: Number of OADs
Number of subjects: 0
Study 27453733 — intervention group
Group type: EXPERIMENTAL
Intervention: Higher education level
Number of subjects: 0
Study 27453733 — intervention group
Group type: EXPERIMENTAL
Intervention: Healthy diet
Number of subjects: 0
Study 27453733 — intervention group
Group type: EXPERIMENTAL
Intervention: Self-monitoring blood glucose
Number of subjects: 0
Study 27453733 — intervention group
Group type: EXPERIMENTAL
Intervention: Hurried communication style in the process of care
Number of subjects: 0
Study 27453733 — intervention group
Group type: EXPERIMENTAL
Intervention: Number of insulin injections
Number of subjects: 0
Study 27453733 — intervention group
Group type: EXPERIMENTAL
Intervention: Adherence
Number of subjects: 0
Study 27453733 — intervention group
Group type: EXPERIMENTAL
Intervention: Not filling insulin prescription due to associated cost
Number of subjects: 0
Study 27453734 — intervention group
Group type: EXPERIMENTAL
Intervention: Metabolic syndrome (MetS) with minor allele G of ESR1 gene polymorphism (rs9340799)
Number of subjects: 1977
Study 27453734 — intervention group
Group type: EXPERIMENTAL
Intervention: Metabolic syndrome (MetS)
Number of subjects: 1977
Study 27453734 — intervention group
Group type: EXPERIMENTAL
Intervention: Interaction of MetS and ESR1 gene polymorphism (rs9340799)
Number of subjects: 1977
Study 27453775 — intervention group
Group type: EXPERIMENTAL
Intervention: Maternal probiotic supplementation
Number of subjects: 259
Study 27454930 — intervention group
Group type: EXPERIMENTAL
Intervention: EndoTAG-1 22mg/m2 plus paclitaxel 70mg/m2
Number of subjects: 20
Study 27455851 — intervention group
Group type: EXPERIMENTAL
Intervention: Aromatase inhibitors (AIs)
Number of subjects: 58
Study 27455851 — intervention group
Group type: COMPARATOR
Intervention: Control (women without cancer diagnoses)
Number of subjects: 58
Study 27455960 — intervention group
Group type: EXPERIMENTAL
Intervention: Nurse-led intervention with the Distress Thermometer (DT) plus usual care
Number of subjects: 0
Study 27455960 — intervention group
Group type: COMPARATOR
Intervention: Usual care
Number of subjects: 0
Study 27455960 — intervention group
Group type: EXPERIMENTAL
Intervention: Nurse-led intervention with the DT plus usual care
Number of subjects: 0
Study 27456232 — intervention group
Group type: EXPERIMENTAL
Intervention: Vitamin D3 (100,000 IU) followed by 400 IU daily for 6 months
Number of subjects: 22
Study 27456232 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 22
Study 27456349 — intervention group
Group type: EXPERIMENTAL
Intervention: Community-driven quality improvement initiatives
Number of subjects: 11
Study 27456349 — intervention group
Group type: EXPERIMENTAL
Intervention: FORGE AHEAD program activities
Number of subjects: 11
Study 27456349 — intervention group
Group type: EXPERIMENTAL
Intervention: Community-level intervention activities
Number of subjects: 11
Study 27456349 — intervention group
Group type: EXPERIMENTAL
Intervention: Program wrap-up activities
Number of subjects: 11
Study 27456703 — intervention group
Group type: EXPERIMENTAL
Intervention: Extracorporeal CO2 removal (ECCO2R) using a pump-driven veno-venous ECCO2R system (iLA-Activve(®); Novalung, Heilbronn, Germany)
Number of subjects: 25
Study 27456703 — intervention group
Group type: COMPARATOR
Intervention: Invasive mechanical ventilation (IMV)
Number of subjects: 25
Study 27456703 — intervention group
Group type: EXPERIMENTAL
Intervention: Extracorporeal CO2 removal (ECCO2R)
Number of subjects: 25
Study 27456710 — intervention group
Group type: EXPERIMENTAL
Intervention: Androgen deprivation therapy (ADT) for none
Number of subjects: 292
Study 27456710 — intervention group
Group type: EXPERIMENTAL
Intervention: Androgen deprivation therapy (ADT) for 1-3 months
Number of subjects: 292
Study 27456710 — intervention group
Group type: EXPERIMENTAL
Intervention: Androgen deprivation therapy (ADT) for 4-12 months
Number of subjects: 292
Study 27456710 — intervention group
Group type: EXPERIMENTAL
Intervention: Low-dose-rate brachytherapy (LDR-BT) with BED <178.0 Gy2
Number of subjects: 292
Study 27456710 — intervention group
Group type: EXPERIMENTAL
Intervention: Low-dose-rate brachytherapy (LDR-BT) with BED ≥178.0 Gy2
Number of subjects: 292
Study 27456710 — intervention group
Group type: EXPERIMENTAL
Intervention: Low-dose-rate brachytherapy (LDR-BT) with or without supplemental EBRT and ADT
Number of subjects: 292
Study 27456841 — intervention group
Group type: EXPERIMENTAL
Intervention: TNFA -308G → A polymorphism (GG homozygotes)
Number of subjects: 230
Study 27456841 — intervention group
Group type: EXPERIMENTAL
Intervention: TNFA -308G → A polymorphism
Number of subjects: 230
Study 27456841 — intervention group
Group type: COMPARATOR
Intervention: MECHE cohort (control group)
Number of subjects: 230
Study 27456845 — intervention group
Group type: EXPERIMENTAL
Intervention: The Healthy Primary School of the Future
Number of subjects: 1200
Study 27456845 — intervention group
Group type: EXPERIMENTAL
Intervention: The Physical Activity School
Number of subjects: 1200
Study 27456845 — intervention group
Group type: COMPARATOR
Intervention: Control schools
Number of subjects: 1200
Study 27457375 — intervention group
Group type: EXPERIMENTAL
Intervention: Triglycerides (TG)
Number of subjects: 455
Study 27457375 — intervention group
Group type: EXPERIMENTAL
Intervention: Triglycerides (TG) combined with Total Cholesterol (TC)
Number of subjects: 455
Study 27457375 — intervention group
Group type: EXPERIMENTAL
Intervention: Triglycerides (TG) combined with Low-Density Lipoprotein (LDL)
Number of subjects: 455
Study 27457469 — intervention group
Group type: EXPERIMENTAL
Intervention: Latanoprostene bunod (LBN) ophthalmic solution 0.024%
Number of subjects: 130
Study 27457512 — intervention group
Group type: EXPERIMENTAL
Intervention: DAPSA remission (REM, ≤4)
Number of subjects: 440
Study 27457512 — intervention group
Group type: EXPERIMENTAL
Intervention: Low disease activity (LDA, ≤14)
Number of subjects: 440
Study 27457512 — intervention group
Group type: EXPERIMENTAL
Intervention: Moderate disease activity (MDA, ≤28)
Number of subjects: 440
Study 27457512 — intervention group
Group type: EXPERIMENTAL
Intervention: High disease activity (HDA, >28)
Number of subjects: 440
Study 27457512 — intervention group
Group type: COMPARATOR
Intervention: TNF inhibitors or placebo (subgroup analysis)
Number of subjects: 440
Study 27457512 — intervention group
Group type: EXPERIMENTAL
Intervention: Health Assessment Questionnaire Disability Index (HAQ)
Number of subjects: 440
Study 27457512 — intervention group
Group type: EXPERIMENTAL
Intervention: Physical component scale of the Short Form-36 (PCS)
Number of subjects: 440
Study 27457584 — intervention group
Group type: EXPERIMENTAL
Intervention: Incidence of AOM
Number of subjects: 0
Study 27457584 — intervention group
Group type: EXPERIMENTAL
Intervention: Incidence of AOM in Slovenia
Number of subjects: 0
Study 27457584 — intervention group
Group type: EXPERIMENTAL
Intervention: Breastfeeding status
Number of subjects: 0
Study 27457584 — intervention group
Group type: EXPERIMENTAL
Intervention: Attendance at school/childcare or presence of allergies
Number of subjects: 0
Study 27457584 — intervention group
Group type: EXPERIMENTAL
Intervention: Doctor visits due to AOM
Number of subjects: 0
Study 27457584 — intervention group
Group type: EXPERIMENTAL
Intervention: Antibiotic prescription rate
Number of subjects: 0
Study 27457584 — intervention group
Group type: EXPERIMENTAL
Intervention: Hospitalization due to AOM
Number of subjects: 0
Study 27457707 — intervention group
Group type: EXPERIMENTAL
Intervention: CEP-37250/KHK2804 (0.03-1.0 mg/kg) intravenously once weekly
Number of subjects: 62
Study 27458003 — intervention group
Group type: EXPERIMENTAL
Intervention: Brentuximab vedotin (BV) and AVD (adriamycin, vinblastine, and dacarbazine) followed by 30 Gy involved site radiation therapy (ISRT)
Number of subjects: 30
Study 27458003 — intervention group
Group type: EXPERIMENTAL
Intervention: Brentuximab vedotin (BV) and AVD (adriamycin, vinblastine, and dacarbazine)
Number of subjects: 30
Study 27459380 — intervention group
Group type: EXPERIMENTAL
Intervention: Prolonged exposure for adolescents (PE-A)
Number of subjects: 61
Study 27459380 — intervention group
Group type: COMPARATOR
Intervention: Client-centered therapy (CCT)
Number of subjects: 61
Study 27459537 — intervention group
Group type: EXPERIMENTAL
Intervention: GLP-1 receptor agonist (GLP-1-RA) exenatide for 9 weeks
Number of subjects: 1
Study 27459537 — intervention group
Group type: EXPERIMENTAL
Intervention: GLP-1 receptor agonist (GLP-1-RA) exenatide
Number of subjects: 1
Study 27459537 — intervention group
Group type: EXPERIMENTAL
Intervention: GLP-1-RA and/or iron chelator deferiprone
Number of subjects: 1
Study 27460041 — intervention group
Group type: EXPERIMENTAL
Intervention: Continuing medical education (CME)
Number of subjects: 831
Study 27460041 — intervention group
Group type: COMPARATOR
Intervention: Reference (non-participating) GPs
Number of subjects: 831
Study 27460105 — intervention group
Group type: EXPERIMENTAL
Intervention: MMP-3 and MMP-10
Number of subjects: 32
Study 27460105 — intervention group
Group type: EXPERIMENTAL
Intervention: MMP-7 and MMP-8
Number of subjects: 32
Study 27460105 — intervention group
Group type: EXPERIMENTAL
Intervention: MMP-9
Number of subjects: 32
Study 27460105 — intervention group
Group type: EXPERIMENTAL
Intervention: Mild CLE
Number of subjects: 32
Study 27460105 — intervention group
Group type: EXPERIMENTAL
Intervention: Multiple MMPs
Number of subjects: 32
Study 27460276 — intervention group
Group type: EXPERIMENTAL
Intervention: Patients with AL amyloidosis
Number of subjects: 1226
Study 27460276 — intervention group
Group type: EXPERIMENTAL
Intervention: Patients with cardiac amyloidosis
Number of subjects: 1226
Study 27460276 — intervention group
Group type: EXPERIMENTAL
Intervention: Patients with cardiac involvement
Number of subjects: 1226
Study 27460276 — intervention group
Group type: EXPERIMENTAL
Intervention: Men
Number of subjects: 1226
Study 27460276 — intervention group
Group type: EXPERIMENTAL
Intervention: Patients ≥65 years
Number of subjects: 1226
Study 27460276 — intervention group
Group type: EXPERIMENTAL
Intervention: Smokers
Number of subjects: 1226
Study 27460276 — intervention group
Group type: EXPERIMENTAL
Intervention: Women
Number of subjects: 1226
Study 27460387 — intervention group
Group type: EXPERIMENTAL
Intervention: EUS-guided pancreatic drainage (EUS-PD)
Number of subjects: 80
Study 27460442 — intervention group
Group type: EXPERIMENTAL
Intervention: Vemurafenib 960 mg orally twice daily (cohort 1)
Number of subjects: 51
Study 27460442 — intervention group
Group type: EXPERIMENTAL
Intervention: Vemurafenib 960 mg orally twice daily (cohort 2)
Number of subjects: 51
Study 27460442 — intervention group
Group type: EXPERIMENTAL
Intervention: Vemurafenib (both cohorts)
Number of subjects: 51
Study 27460442 — intervention group
Group type: COMPARATOR
Intervention: Control group (not specified)
Number of subjects: 51
Study 27460571 — intervention group
Group type: EXPERIMENTAL
Intervention: Rituximab-based chemotherapy (R-chemo)
Number of subjects: 0
Study 27461213 — intervention group
Group type: EXPERIMENTAL
Intervention: Dapagliflozin
Number of subjects: 5936
Study 27461255 — intervention group
Group type: EXPERIMENTAL
Intervention: Induction neoadjuvant chemotherapy (NACT)
Number of subjects: 0
Study 27461255 — intervention group
Group type: EXPERIMENTAL
Intervention: Sequential chemoradiotherapy (CRT)
Number of subjects: 0
Study 27461255 — intervention group
Group type: EXPERIMENTAL
Intervention: Post-NACT matrix metalloproteinase-9 levels
Number of subjects: 0
Study 27461255 — intervention group
Group type: COMPARATOR
Intervention: Diarrhea scores
Number of subjects: 0
Study 27462120 — intervention group
Group type: EXPERIMENTAL
Intervention: Healthy smokers who quit smoking for 12 months
Number of subjects: 61
Study 27462120 — intervention group
Group type: EXPERIMENTAL
Intervention: COPD smokers who quit smoking for 12 months
Number of subjects: 61
Study 27462120 — intervention group
Group type: COMPARATOR
Intervention: Healthy smokers who continued smoking
Number of subjects: 61
Study 27462120 — intervention group
Group type: COMPARATOR
Intervention: COPD smokers who continued smoking
Number of subjects: 61
Study 27462386 — intervention group
Group type: EXPERIMENTAL
Intervention: Calcipotriene/betamethasone topical suspension (once-daily)
Number of subjects: 8
Study 27462400 — intervention group
Group type: EXPERIMENTAL
Intervention: Ferumoxytol
Number of subjects: 767
Study 27462400 — intervention group
Group type: COMPARATOR
Intervention: Iron sucrose
Number of subjects: 767
Study 27463414 — intervention group
Group type: EXPERIMENTAL
Intervention: ipragliflozin
Number of subjects: 3481
Study 27463628 — intervention group
Group type: EXPERIMENTAL
Intervention: AcrySof® ReSTOR® SN6AD1
Number of subjects: 37
Study 27463628 — intervention group
Group type: EXPERIMENTAL
Intervention: AMO Tecnis® ZMB00
Number of subjects: 37
Study 27463628 — intervention group
Group type: COMPARATOR
Intervention: Comparison of both lenses
Number of subjects: 37
Study 27463639 — intervention group
Group type: EXPERIMENTAL
Intervention: Interpersonal psychotherapy (IPT) delivered by nonspecialists
Number of subjects: 0
Study 27463733 — intervention group
Group type: EXPERIMENTAL
Intervention: Rituximab (two infusions of 1000 mg at month 0 and 6, plus 100 mg methylprednisolone)
Number of subjects: 14
Study 27464202 — intervention group
Group type: EXPERIMENTAL
Intervention: HMW multimers normalization in patients without aortic regurgitation (137 patients)
Number of subjects: 183
Study 27464202 — intervention group
Group type: EXPERIMENTAL
Intervention: CT-ADP assessment
Number of subjects: 183
Study 27464202 — intervention group
Group type: EXPERIMENTAL
Intervention: HMW multimers and CT-ADP values at the end of TAVR
Number of subjects: 183
Study 27464316 — intervention group
Group type: EXPERIMENTAL
Intervention: Presence of Major Depressive Episode (MDE)
Number of subjects: 235
Study 27464316 — intervention group
Group type: COMPARATOR
Intervention: Antidepressant use
Number of subjects: 235